COMPAGNIE LOMBARD ODIER SCMA Regeneron Pharmaceuticals, Inc. Transaction History

COMPAGNIE LOMBARD ODIER SCMA portfolio value:

$1.29M
portfolio value

COMPAGNIE LOMBARD ODIER SCMA quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 181K $688.87 1.88K
Q2 2022 share 0.00% 0 shares -200K $591.13 1.88K
Q1 2022 share 0.00% 0 shares 125K $698.42 1.88K
Q4 2021 share 0.00% 0 shares 50K $642.51 1.88K
Q3 2021 share Increase +75.70% 810 shares 540K $605.18 1.88K
Q2 2021 share Decrease -8.94% -105 shares 42K $558.54 1.07K
Q1 2021 share Decrease -12.96% -175 shares -96K $473.14 1.17K
Q4 2020 share Increase +6.30% 80 shares -59K $483.11 1.35K
Q3 2020 share Increase +28.28% 280 shares 94K $559.78 1.27K
Q2 2020 share Decrease -16.10% -190 shares 41K $623.65 990
Q1 2020 share Increase +47.50% 380 shares 276K $488.29 1.18K
Q4 2019 share Decrease -11.21% -101 shares 50K $375.48 800
Q3 2019 share 0.00% 0 shares -32K $277.4 901
Q2 2019 share Decrease -23.51% -277 shares -201K $313 901
Q1 2019 share Decrease -20.30% -300 shares -69K $410.62 1.17K
Q4 2018 share Increase +5.57% 78 shares -14K $373.5 1.47K
Q3 2018 share 0.00% 0 shares 83K $404.04 1.4K
Q2 2018 share Decrease -4.11% -60 shares -20K $344.99 1.4K
Q1 2018 share Decrease -2.21% -33 shares -58K $344.36 1.46K
Q4 2017 share Increase 0.00% 1.49K shares 561K $375.96 1.49K
Q2 2017 share Decrease -100.00% -70 shares -27K $491.14 0
Q1 2017 share Increase 0.00% 70 shares 27K $387.51 70